MedPath

To test the effectiveness of two drugs for spinal anaesthesia in below umbilical surgeries.

Not Applicable
Conditions
Health Condition 1: S318- Open wound of other parts of abdomen, lower back and pelvis
Registration Number
CTRI/2023/07/055159
Lead Sponsor
ot Applicable
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Age group 18-60 years of either age. 2) Patients with ASA grade I and II 3) patients with average height ( >5 feet). 4) All patients undergoing infra-umbilical surgeries

Exclusion Criteria

1) Patient refusal or not giving consent.

2) Patients with the Neurological disease,

bleeding diathesis, Coagulopathy disorders.

3) Patients with spine/Neurological deformities,

4) Local Skin infections or disease.

5) History of drug allergy.

6) Patients on tranquilizers, hypnotics, sedatives

and other psychotropic drugs.

7) Severe liver or kidney diseases.

8) ASA grade III and IV, V.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the effects of Hyperbaric Levobupivacaine (0.5%) & Hyperbaric Bupivacaine (0.5%) on the onset & duration of sensory and motor block and to evaluate perioperative hemodynamic effectsTimepoint: Immediately after induction till 180 minutes.
Secondary Outcome Measures
NameTimeMethod
To evaluate the post-operative analgesia. <br/ ><br>To evaluate the occurrence of side effects & complications, if any. <br/ ><br>Timepoint: Immediately after induction till 180 minutes.
© Copyright 2025. All Rights Reserved by MedPath